Avenue Therapeutics, Inc. (ATXI)
ATXI moved a median of 0.00% 30 minutes after news, and -0.37% by the close. How ATXI actually reacts to news — the realized, point-in-time move the market made, measured across 120 labeled events over the last three years with zero look-ahead.
ATXI’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 28% | 108 |
| 30-min | 0.00% | 37% | 115 |
| 60-min | -0.06% | 34% | 116 |
| to close | -0.37% | 42% | 118 |
| Middle 50% of ATXI reactions | -2.65% to +0.92% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 120 |
Half of all Avenue Therapeutics, Inc. news events land between -2.65% and +0.92% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when ATXI moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ATXI's baseline. Nothing else.
Recent ATXI events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 10-Q AVENUE THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -47.69% | |
| Form 10-Q AVENUE THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -3.67% | |
| Form 10-K AVENUE THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | — | — | |
| Form 8-K AVENUE THERAPEUTICS, For: Feb 18 | SEC filing · Form 8-K | SEC EDGAR | +28.01% | +42.06% | |
| Form 8-K AVENUE THERAPEUTICS, For: Dec 30 | SEC filing · Form 8-K | SEC EDGAR | -3.50% | -4.87% | |
| Form EFFECT AVENUE THERAPEUTICS, | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | +0.08% | |
| Form POS AM AVENUE THERAPEUTICS, | SEC filing · Form POS | SEC EDGAR | +0.00% | +3.73% | |
| Form RW AVENUE THERAPEUTICS, | SEC filing · Form RW | SEC EDGAR | +0.00% | +3.73% | |
| Form DEF 14A AVENUE THERAPEUTICS, For: Dec 30 | SEC filing · Form DEF | SEC EDGAR | +0.00% | -12.64% | |
| Form 8-K AVENUE THERAPEUTICS, For: Nov 14 | SEC filing · Form 8-K | SEC EDGAR | +14.28% | +2.23% | |
| Form 8-K AVENUE THERAPEUTICS, For: Nov 05 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.13% | |
| Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics | Press release | GlobeNewswire | +0.00% | -11.77% | |
| Form 10-Q AVENUE THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +20.57% | +61.47% | |
| Form 10-Q AVENUE THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K AVENUE THERAPEUTICS, For: Apr 24 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form 10-K AVENUE THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +1.20% | -3.33% | |
| Form 8-K AVENUE THERAPEUTICS, For: Mar 17 | SEC filing · Form 8-K | SEC EDGAR | -7.10% | -23.50% | |
| Form 8-K AVENUE THERAPEUTICS, For: Mar 07 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +5.05% | |
| Form S-3 AVENUE THERAPEUTICS, | SEC filing · Form S-3 | SEC EDGAR | +0.00% | -2.67% | |
| Form 8-K AVENUE THERAPEUTICS, For: Nov 26 | SEC filing · Form 8-K | SEC EDGAR | -2.72% | +5.43% | |
| Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights | Press release | GlobeNewswire | -3.23% | +3.76% | |
| Form 10-Q AVENUE THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -3.23% | +3.76% | |
| Form 8-K AVENUE THERAPEUTICS, For: Nov 14 | SEC filing · Form 8-K | SEC EDGAR | -3.23% | +3.76% | |
| Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit | Press release | GlobeNewswire | +0.00% | +0.51% | |
| Form 8-K AVENUE THERAPEUTICS, For: Sep 23 | SEC filing · Form 8-K | SEC EDGAR | -2.72% | -3.11% | |
| Avenue Therapeutics to Participate in Upcoming Investor Conferences | Press release | GlobeNewswire | — | +9.84% | |
| Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights | Press release | GlobeNewswire | — | +1.63% | |
| Form 10-Q AVENUE THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | — | +1.63% | |
| Form 8-K AVENUE THERAPEUTICS, For: Aug 09 | SEC filing · Form 8-K | SEC EDGAR | — | +1.63% | |
| Form S-8 AVENUE THERAPEUTICS, | SEC filing · Form S-8 | SEC EDGAR | — | +2.05% | |
| Form 8-K AVENUE THERAPEUTICS, For: Jun 24 | SEC filing · Form 8-K | SEC EDGAR | -1.61% | -0.83% | |
| Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference | Press release | GlobeNewswire | +7.14% | -2.29% | |
| Form 8-K AVENUE THERAPEUTICS, For: May 21 | SEC filing · Form 8-K | SEC EDGAR | -0.21% | -3.98% | |
| Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease) | Press release | GlobeNewswire | +3.54% | -1.09% | |
| Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights | Press release | GlobeNewswire | -0.27% | -1.62% | |
| Form 10-Q AVENUE THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +3.54% | -1.09% | |
| Form 8-K AVENUE THERAPEUTICS, For: May 15 | SEC filing · Form 8-K | SEC EDGAR | -0.27% | -1.62% | |
| Form 8-K AVENUE THERAPEUTICS, For: May 10 | SEC filing · Form 8-K | SEC EDGAR | -0.26% | +2.33% | |
| Form EFFECT AVENUE THERAPEUTICS, | SEC filing · Form EFFECT | SEC EDGAR | -0.26% | +2.33% | |
| Form DEF 14A AVENUE THERAPEUTICS, For: Jun 22 | SEC filing · Form DEF | SEC EDGAR | +0.21% | -3.63% | |
| Form DEFA14A AVENUE THERAPEUTICS, | SEC filing · Form DEFA14A | SEC EDGAR | +0.21% | -3.63% | |
| Form S-3 AVENUE THERAPEUTICS, | SEC filing · Form S-3 | SEC EDGAR | +0.21% | -3.63% | |
| Form 8-K AVENUE THERAPEUTICS, For: May 01 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.63% | |
| Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds | Press release | GlobeNewswire | -0.99% | -10.95% | |
| Form 8-K AVENUE THERAPEUTICS, For: Apr 25 | SEC filing · Form 8-K | SEC EDGAR | -0.99% | -10.95% | |
| Avenue Therapeutics Announces Reverse Stock Split | Press release | GlobeNewswire | -7.69% | -5.79% | |
| Form 8-K AVENUE THERAPEUTICS, For: Mar 26 | SEC filing · Form 8-K | SEC EDGAR | -1.82% | -2.53% | |
| Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024 | Press release | GlobeNewswire | -0.47% | +4.03% | |
| Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights | Press release | GlobeNewswire | -3.85% | -3.61% | |
| Form 10-K AVENUE THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -3.85% | -3.61% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ATXI section they belong to.
Where else ATXI is measured.
ATXI earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Protagenic Therapeutics, Inc. (PTIX) | 121 | 0.00% | 39% |
| Xenetic Biosciences, Inc. (XBIO) | 121 | 0.00% | 38% |
| CARL ZEISS MEDI UNSP/ADR (CZMWY) | 120 | -0.21% | 21% |
| HEMP NATURALS INC (HPMM) | 120 | 0.00% | 37% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Avenue Therapeutics, Inc.'s median reaction calculated?
Every labeled ATXI news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 120 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 37% of ATXI's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does ATXI's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.